Mir A. Hoda

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 100 publications

MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

Journal: Diagnostics (Basel, Switzerland)

Published: March 03, 2026

Current advances in extended resections for non-small cell lung cancer-a narrative review.

Current advances in extended resections for non-small cell lung cancer-a narrative review.

Journal: Translational lung cancer research

Published: March 01, 2026

Targeting P2RY2 reprograms tumor immunity and inhibits tumor growth in non-small cell lung cancer.

Targeting P2RY2 reprograms tumor immunity and inhibits tumor growth in non-small cell lung cancer.

Journal: Cancer letters

Published: November 11, 2025

Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma.

Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma.

Journal: Antioxidants (Basel, Switzerland)

Published: November 07, 2025

Surgical Results after Neoadjuvant Nivolumab and Platinum-based Chemotherapy for Resectable Lung Cancer. A Multicentre European Real Clinical Practice Analysis.

Surgical Results after Neoadjuvant Nivolumab and Platinum-based Chemotherapy for Resectable Lung Cancer. A Multicentre European Real Clinical Practice Analysis.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: July 30, 2025

Transbronchial Cryobiopsy under Simultaneous Confocal Laser Endomicroscopy Guidance for Peripheral Pulmonary Lesions: A Pilot Study.

Transbronchial Cryobiopsy under Simultaneous Confocal Laser Endomicroscopy Guidance for Peripheral Pulmonary Lesions: A Pilot Study.

Journal: Respiration; international review of thoracic diseases

Published: May 29, 2025

Management and Outcomes of Pulmonary Nodules in a Real-World Setting.

Management and Outcomes of Pulmonary Nodules in a Real-World Setting.

Journal: Diagnostics (Basel, Switzerland)

Published: May 20, 2025

ESR Bridges: lung cancer: new developments in imaging and treatment-a multidisciplinary view.

ESR Bridges: lung cancer: new developments in imaging and treatment-a multidisciplinary view.

Journal: European radiology

Published: April 02, 2025

The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma.

The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma.

Journal: Cancers

Published: March 31, 2025

Current perspective on resectability in stage III locally advanced NSCLC - The thoracic surgeons' view.

Current perspective on resectability in stage III locally advanced NSCLC - The thoracic surgeons' view.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 18, 2025

Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma.

Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma.

Journal: British journal of cancer

Published: March 04, 2025

Impact of Neoadjuvant and Adjuvant Pleural Intensity-Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma.

Impact of Neoadjuvant and Adjuvant Pleural Intensity-Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma.

Journal: Thoracic cancer

Published: November 17, 2024

Showing 1-12 of 100

Last Updated: 09/26/2026